Steven Bernstein
Analyst · the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this conference call. It is now my pleasure to introduce your host, Stanton Sloane, President and CEO
Thank you, Stan. And good afternoon. For the 6 months ended October 31, 2021, consolidated revenue was $26 million compared to $27 million for the same period of the prior fiscal year. The components of revenue are as follows. Revenue from commercial and US Government satellite programs was approximately $13.3 million or 51% compared to $14.2 million or 53% in the same period of the prior fiscal year. Revenues on satellite payload contracts are recognized primarily under the percentage of completion method and are recorded only in the FEI-New York segment. Revenues from non-space US Government and DOD customers, which are recorded in both the FEI-New York and FEI-Zyfer segments, were $10.6 million compared to $10.9 million in the same period of the prior fiscal year and accounted for approximately 41% of consolidated revenue compared to 40% for the prior fiscal year. Other commercial and industrial revenues were $2 million compared to $1.8 million in the prior fiscal year. Intersegment revenues are eliminated in consolidation. For the 6 months ended October 31, 2021, gross margin and gross margin rate decreased as compared to the same period in fiscal year '21. The decrease in gross margin and gross margin rate was due to increased engineering cost on development phase programs that experience particularly complex technical challenges, as well as cost impacts on several programs resulting from supply chain problems, lack of availability of parts and materials and quality problems with traditional vendors, resulting in the need to redesign certain electronic units to replace unavailable parts with different parts that were available in order to maintain contract delivery schedules. In several cases, re-procurement of circuit boards and mechanical parts was necessitated by quality issues in the supply chain, further contributing to increased costs. For the 6 months ended October 31, 2021 and 2020, selling and administrative expenses were approximately 26% and 27%, respectively, of consolidated revenues. The decrease in SG&A expense is mainly due to the decrease in professional fees. We expect this trend to continue as expenses normalize. R&D expense for the 6 months ended October 31, 2021 and 2020 increased to $2.7 million from $2.2 million, an increase of $500,000 and were 11% and 8% of consolidated revenue. R&D increases in the first and second quarters of fiscal '22 were due to higher-than-usual levels of internal R&D associated with investments the company is making in new technology developments related to atomic clocks and low-noise oscillators that are intended to produce long-term increases in revenue and position the company to compete in the marketplace with next-generation products. The company plans to continue to invest in R&D to keep its products at the state-of-the-art. For the 6 months ended October 31, 2021, the company recorded an operating loss of $1.4 million compared to an operating loss of $120,000 in the prior year. The factors cited above in the gross margin discussion are applicable [ph] to operating income as well. It is important to mention that for the 3 months period ending October 31, 2021, the company reported an operating profit of $303,000, a significant improvement from the first quarter. Other income - I'm sorry, for the 6 months ended October 31, 2021, the company recorded an operating loss of $1.4 million compared to an operating loss of $120,000 in the prior year. Other income consisted primarily of investment income derived from the company's holdings of marketable securities. Earnings on securities may vary based on fluctuating interest rates, dividend payout levels and the timing of purchases, sales, redemptions or maturities of securities. For the 6 months ended October 31, 2021, investment income included $123,000 dividend from Morion compared to $105,000 dividend from Morion in the same period in fiscal '21. This yields a pretax loss of approximately $1.1 million compared to $92,000 of pretax income for the prior year. For the 6 months ending October 31, 2021, the company recorded a tax provision of $2,000 compared to $25,000 for the prior fiscal year. Consolidated net loss for the 6 months ending October 31, 2021, was $1.1 million or $0.12 per share compared to $67,000 of net income or $0.01 per share in the previous fiscal year. Our fully funded backlog at the end of October 21 was approximately $38 million, down approximately $2 million from the previous fiscal year ended April 30, 2021. The company's balance sheet continues to reflect the strong working capital position of approximately $40 million on October 31, 2021, and a current ratio of approximately 5 to 1. Additionally, the company is debt free. The company believes that its liquidity is adequate to meet its operating investing needs for the next 12 months and foreseeable future. I will turn the call back to Stan, and we look forward to your questions.